Who are the 10 key players in the $226B spine biologics market?

The global spine biologics market is projected to grow at a 4.4 percent compound annual growth rate, from $226 billion in 2018 to $280 billion by 2023, according to a Market Data Forecast report.

Advertisement
By: Staff

Here are the top 10 players in the market:

1. Alphatec Holdings

2. DePuy Synthes

3. Exactech

4. Globus Medical

5. Medtronic

6. NuVasive

7. Orthofix

8. RTI Surgical

9. SeaSpine

10. Zimmer Biomet

More articles on biologics:

206 Ortho gets bio-inspired patent: 3 quick notes

Emory Orthopaedics & Spine Center receives $13M to study stem cell osteoarthritis treatments: 4 notes

Bone Biologics raises $5.9M: 3 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

The revenue cycle at a turning point: How managed services are helping healthcare leaders stabilize margins and prepare for what’s next

Recommended Whitepaper

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.